Clinical Trial Update: Effect of Dapagliflozin on Cardiac Structure, Function and Secondary Mitral Regurgitation in Patients with Left Ventricle Dysfunction [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing dapagliflozin in patients with left ventricular dysfunction due to dilated cardiomyopathy has completed, examining effects on cardiac …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: October 6 University | Conditions: Dilated Cardiomyopathy | Phase 3 | Status: COMPLETED